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LIVERTRANSPLANTATION INTHETREATMENTOF
BLEEDING OESOPHAGEAL VARICES
ABSTRACT
S. lwatsuki, T.E. Starzl, S. Todo, R.D. Gordon, A.G. Tzakis, J. W. Marsh, L. Makowka,
B. Koneru, A. Stieber, G. Klintmalm, B. Husberg, D. van Thiel. (1988) Liver
transplantation in the treatment ofbleeding esophageal varices. Surgery, 104; 697-705.
From March 1980 to July 1987, 1000 patients with various end-stage liver diseases
received orthotopic liver transplants. Ofthe 1000 patients, three hundred two had definite
histories of bleeding from esophageal varices before transplantation. There were 287
patients with nonalcoholic liver diseases and 15 patients with alcoholic cirrhosis. All
patients had very poor liver function, which was the main indication for liver
transplantation. One- through 5-year actuarial survival rates of the 302 patients were
79%, 74%, 71%, 71%, and 71%, respectively. These survival rates are far better than
those obtained with other available modes of treatment for bleeding varices when liver
disease is advanced. Long-term sclerotherapy is the treatment of primary choice for
bleeding varices. Patients in whom sclerotherapy fails should be considered for liver
transplantation unless clear contraindications exist.
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In the manuscript under review, Iwatsuki and associates have retrospectively
evaluated 1,000 patients undergoing orthotopic liver transplantation at the University
ofColorado, University of Pittsburgh, and the Pittsburgh affiliated Baylor University
Medical Center in Dallas between March 1980 and July 1987. All ofthese patients were
transplanted in the cyclosporine-era, during which results have been considerably
better than those achieved prior to 1980. Although all transplants were done for end-
stage liver disease, a review ofthe pre-transplant courses revealed that 302 patients had
bled from varices. For reasons that are not clear, the group of patients who had
experienced variceal hemorrhage had significantly better survival after transplantation
than had those patients without a history of variceal bleeding.
Variceal hemorrhage had been treated by endoscopic sclerotherapy in 219 patients,
by portal-systemic shunt in 37 patients (nonselective 22, selective 15), and by a
devascularization, nonshunt procedure in five patients. It is not specified in the
manuscript whether any of the previously operated patients had also undergone
sclerotherapy. Only ten individuals (3%) were bleeding from varices in the immediate
pre-transplant interval. Kaplan-Meier analysis showed no significant difference in
survival between the 42 patients who had undergone prior surgery for variceal
hemorrhage and the 260 patients who had received only sclerotherapy or no treatment
for variceal bleeding, although the former group had a slightly higher one-month
mortality (17% versus 8%).
The authors show that their survival results oftransplant patients with prior variceal
bleeding compare favorably to several other published series of shunt surgery,
nonshunt operations, and sclerotherapy; and that survival after transplantation is
clearly superior to survival data from other series of variceal bleeders when only
Child’s C patients are included in the analysis. Iwatsuki and co-workers conclude that
long-term sclerotherapy is the preferred treatment for variceal hemorrhage and that,
unless clear contraindications exist, hepatic transplantation should be done if and
when sclerotherapy fails or end-stage liver disease develops. In other words, they state
that non-transplant surgery for bleeding varices is rarely, if ever, indicated. Are these
conclusions justified from the data presented?
I believe that the authors’ conclusions are appropriate for the population ofpatients
included in their investigation. All of these patients apparently had end-stage liver
disease and were reasonable candidates for liver transplantation. However, these are
highly selected, referred patients with almost exclusively nonalcoholic liver diseases. In
addition, a significant percentage of the patients were in the pediatric age range.
Therefore, it is inappropriate to compare the survival of these patients after
transplantation with the predominantly adult, alcoholic cirrhotic patients included in
the several reports referred to in the discussion section of their manuscript.
Additionally, the patients who comprised these various series presented with the
problem of variceal hemorrhage and were specifically treated either emergently or
electively for that complication of portal hypertension. In contrast, only 3% of the
variceal bleeders in Iwatsuki’s report were actively bleeding at the time of
transplantation.
In addition to hepatic transplantation, there are .available to the physician or
surgeon pharmacotherapy, sclerotherapy, and a large variety of shunt and nonshunt
operations when treating patients with variceal hemorrhage in 1989. Transplantation
is the only one of these therapies that addresses the underlying liver disease in addition
to preventing recurrent bleeding. Considering the excellent post-transplantation long-368 HPB INTERNATIONAL
term survival rates, which have been demonstrated in several centers throughout the
world, few would argue with the concept that transplantation is the preferred
treatment for many patients with marginal hepatic functional reserve or a poor quality
of life secondary to their liver disease, whether or not they have bled from varices.
Unfortunately, many variceal bleeders are not appropriate transplant candidates and,
even if they were, the supply ofdonor organs would never meet the demand. The most
common causes of variceal hemorrhage world-wide are schistosomiasis, a disease in
which hepatic functional reserve is often indefinitely maintained, and alcoholic
cirrhosis, an affliction often accompanied by dysfunction ofother major organ systems
and/or incurable alcoholism. Although carefully selected patients with alcoholic
cirrhosis have been successfully transplanted2, it is unlikely that this treatment will ever
be applicable to the majority of patients with this disorder. Likewise, several patients
with nonalcoholic liver disease are not transplant candidates because ofage, coexisting
diseases, or financial resources. Therefore, other means of preventing recurrent
hemorrhage in patients with portal hypertension need to be considered.
Recent controlled trials3-5 of sclerotherapy versus the distal splenorenal shunt
suggest that endoscopic variceal sclerosis is a reasonable initial therapy for most
cirrhotics with variceal hemorrhage. Exceptions include noncompliant patients, those
living at great distances from tertiary medical care, and individuals who bleed from
gastric varices or portal hypertensive gastropathy4. Unless these latter patients present
with marginal hepatic functional reserve and are otherwise reasonable transplant
candidates, a portal-systemic shunt or nonshunt operation needs to be done to prevent
exsanguination. In addition, approximately one-third of patients managed with long-
term variceal sclerosis will eventually fail this mode of therapy and require another
treatment to prevent recurrent hemorrhage3’4. One trial3 has shown that most
sclerotherapy failures can be salvaged by shunt surgery while a second study4 including
more noncompliant patients living in geographically remote areas, showed a lower
salvage rate for sclerotherapy failures.
Although Iwatsuki implies in the discussion of his results that patients transplanted
without prior surgery for portal hypertension survived longer than those who had
undergone portal systemic shunts prior to transplantation, his own analysis of these
two groups showed no significant differences in survival. The survival of previously
shunted patients might have been even better if subsequent transplantation had been
considered at the time ofthe initial operation. Although the specific types ofshunts are
not listed, presumably many of the nonselective shunts were of the portacaval variety,
which make subsequent hepatic transplantation a much more challenging technical
feat. Others6 have suggested that, when portal-systemic shunt surgery is necessary in
patients who may be future candidates for transplantation, the porta hepatis should be
avoided and either a distal splenorenal shunt or an interposition mesocaval shunt
constructed. I prefer selective variceal decompression for most patients because
hepatic portal perfusion is maintained in a significant percentage and analysis of all of
the controlled data available suggests that postoperative encephalopathy is less
frequent following selective shunts than after nonselective shunting procedures7.
In conclusion, hepatic transplantation is appropriate therapy for some variceal
bleeders either as initial treatment or after they have failed sclerotherapy. However,
patients who fail sclerotherapy and are either not candidates for transplantation or
who have slowly progressive hepatocellular disease with good functional reserve
should undergo selective or nonselective portal decompression or a nonshunting
operation depending on each individual’s hemodynamic status and clinical
circumstancess. The only meaningful way to compare these various treatment schemesHPB INTERNATIONAL 369
in a clinical investigation would be to include only potential transplant candidates at
the outset. Ideally, such a study would be randomized with one arm including patients
who either underwent initial hepatic transplantation or transplantation after
sclerotherapy failure and the second arm consisting ofindividuals who would receive a
shunt operation after sclerotherapy if their hepatic functional reserve was well
maintained. This group would then undergo transplantation as a back-up to shunt
surgery when end-stage liver disease was apparent. Because many variceal bleeders are
not candidates for hepatic transplantation, it would be difficult to accrue a sufficient
number of patients to such an investigation to provide meaningful results.
Layton F. Rikkers, M.D.
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SURGERY OR ENDOPROSTHESIS FOR MALIGNANT
OBSTRUCTIVE JAUNDICE
ABSTRACT
Shepherd HA, Royle G, Ross APR, Diba A, Arthur M and Colin-Jones D (1988)
Endoscopic biliary endoprosthesis in the palliation ofmalignant obstruction of the distal
common bile duct." a randomized trial. British Journal ofSurgery; 75.’1166-1168
A total of 52 jaundiced elderly patients who had malignant obstruction of the distal
common bile duct and who required palliative biliary decompression were randomized to